2024    2023    2022    2021    2020    2019    2018    2017    2016   

2022

Articles avec comité de lecture de revues internationales

21 - 

Alcohol-related liver disease treatment and EBM

Alain Braillon, Florian Naudet

Liver International, 2022, 42 (8), pp.1909-1909.

DOI : https://doi.org/10.1111/liv.15336

Pubmed : 35686691

 

22 - 

The underutilization of medications for alcohol use disorders is a sensible choice

Alain Braillon, Florian Naudet

European Journal of Internal Medicine, 2022, 104, pp.120-121.

DOI : https://doi.org/10.1016/j.ejim.2022.07.023

Pubmed : 35927187

 

23 - 

Antidepressants are not safe during pregnancy and in women of child-bearing age

Alain Braillon, Susan Bewley, Aubrey Blumsohn, Florian Naudet, Jean-Louis Montastruc, Joel R Lexchin

British Journal of Clinical Pharmacology, 2022, 88 (5), pp.2447-2448.

DOI : https://doi.org/10.1111/bcp.15142

Pubmed : 34904264

 

24 - 

Altered epithelial barrier functions in the colon of patients with spina bifida

Charlène Brochard, Guillaume Bouguen, Raphael Olivier, Tony Durand, Sébastien Henno, Benoît Peyronnet, Mael Pagenault, Chloé Lefèvre, Gaëlle Boudry, Mikael Croyal, Alain Fautrel, Maxime Esvan, Alain Ropert, Anne Dariel, Laurent Siproudhis, Michel Neunlist

Scientific Reports, 2022, 12 (1), pp.7196.

DOI : https://doi.org/10.1038/s41598-022-11289-3

Pubmed : 35505001

 

25 - 

Natural History of Perianal Crohn's Disease: Long-term Follow-up of a Population-Based Cohort

Charlène Brochard, Marie-Laure Rabilloud, Stéphanie Hamonic, Emma Bajeux, Mael Pagenault, Alain Dabadie, Agathe Gerfaud, J.-F. Viel, Isabelle Tron, Michel Robaszkiewicz, Jean-François Bretagne, Laurent Siproudhis, Guillaume Bouguen

Clinical Gastroenterology and Hepatology, 2022, 20 (2), pp.e102-e110.

DOI : https://doi.org/10.1016/j.cgh.2020.12.024

Pubmed : 33359730

 

26 - 

Gut microbiota analysis for prediction of clinical relapse in Crohn’s disease

Sylvie Buffet-Bataillon, Guillaume Bouguen, François Fleury, Vincent Cattoir, Yann Le Cunff

Scientific Reports, 2022, 12 (1), pp.19929.

DOI : https://doi.org/10.1038/s41598-022-23757-x

Pubmed : 36402792

 

27 - 

DOP76 Real-world multicenter comparison of effectiveness between tofacitinib and vedolizumab in patients with Ulcerative Colitis after failure to at least one anti-TNF agent

A. Buisson, M. Nachury, Mathurin Fumery, T. Guilmoteau, E. Leclerc, R. Altwegg, M. Serrero, X. Treton, L. Vuitton, B. Pereira, A. Amiot, G. Bouguen

Journal of Crohn's and Colitis, 2022, 16 (1), pp.I120.

DOI : https://doi.org/10.1093/ecco-jcc/jjab232.115

 

28 - 

Sclerosing tenosynovitis in a patient with pan-sclerotic morphea

L Caillault, Guillaume Coiffier, François Robin, Catherine Droitcourt, Alain Lescoat

Joint Bone Spine, 2022, 89 (6), pp.105421.

DOI : https://doi.org/10.1016/j.jbspin.2022.105421

Pubmed : 35671975

 

29 - 

Synovitis and tenosynovitis of the hands and wrists in patients with SSc: The need for a consensus definition of sclerosing tenosynovitis

Leïla Caillault, Catherine Droitcourt, François Robin, Marine Tas, Guillaume Coiffier, Alain Lescoat

Seminars in Arthritis and Rheumatism, 2022, 52, pp.151901.

DOI : https://doi.org/10.1016/j.semarthrit.2021.08.009

Pubmed : 34493395

 

30 - 

Disease reactivation after fingolimod cessation in Multiple Sclerosis patients with pregnancy desire: A retrospective study

Alix Callens, Soline Leblanc, Emmanuelle Le Page, Gilles Edan, Aurore Jourdain, Marc Coustans, Sandrine Wiertlewski, David Laplaud, Dorothée Videt, Francois Lallement, Emmanuelle Leray, Laure Michel

Multiple Sclerosis and Related Disorders, 2022, 66, pp.104066.

DOI : https://doi.org/10.1016/j.msard.2022.104066

Pubmed : 35908450